miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells (Q38840273)

6 September 2017

miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells (English)

1 reference

6 September 2017

1 reference

Vildan Bozok Çetintaş

1

1 reference

6 September 2017

Aslı Tetik Vardarlı

2

1 reference

6 September 2017

Zekeriya Düzgün

3

1 reference

6 September 2017

Burçin Tezcanlı Kaymaz

4

1 reference

6 September 2017

Eda Açıkgöz

5

1 reference

6 September 2017

Hüseyin Aktuğ

6

1 reference

6 September 2017

Buket Kosova Can

7

1 reference

6 September 2017

Cumhur Gündüz

8

1 reference

6 September 2017

Zuhal Eroğlu

9

1 reference

6 September 2017

28 August 2015

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

2

1 reference

6 September 2017

1739-1751

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3950-9

6 September 2017

0 references

cites work

Cisplatin in cancer therapy: molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

MicroRNA-modulated autophagic signaling networks in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Autophagy regulation by miRNAs: when cleaning goes out of service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

21 January 2018

MicroRNAs in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Eaten alive: a history of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Autophagy-A double-edged sword in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Autophagy and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

The emerging role of microRNAs in resistance to lung cancer treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Role of autophagy in cisplatin resistance in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

MiR-15a-16 represses Cripto and inhibits NSCLC cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Cell cycle deregulation in B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Bcl-2 inhibition of autophagy: a new route to cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

A cellular stress-directed bistable switch controls the crosstalk between autophagy and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Cisplatin resistance induced by decreased apoptotic activity in non-small-cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3950-9

Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.

21 January 2018

1 reference

12 December 2020

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

1 reference

12 December 2020

Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells.

1 reference

12 December 2020

Roscovitine-treated HeLa cells finalize autophagy later than apoptosis by downregulating Bcl‑2.

1 reference

12 December 2020

The anticancer drug imatinib induces cellular autophagy.

1 reference

12 December 2020

miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway

1 reference

12 December 2020

Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments

1 reference

12 December 2020

10.1007/S13277-015-3950-9

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference